A group of funds managed by Mario Gabelli's Gamco Investors reported holdings of about 3.06 million shares (6.94%) in the molecular diagnostics company. It purchased the stake from June 9 to July 2 at $11.11 to $11.20 a share.

Outperform - Price 11.15 on June 10
by Baird Securities

Hologic announced...a definitive agreement to acquire TWTI in a cash deal worth $11.25/share, [which we see as] positive for TWTI shareholders. Our 12 target is based on target price/sales multiple of 9 times, which we think is in line with historical P/S range of six to 13 times in comparative...specialty diagnostics. We're using a 2009 sales basis for TWTI to reflect its potential [to enter] high-growth markets such as [human papillomavirus] and pharmacogenomics. Market cap: $488 million.

Madison, WI has attracted a lot of biotechnology firms.

I know the CEO. Great guy. Brilliant guy. Born leader. Humble guy. The best combination for a CEO. He will make this company a success.

SOLD